Kouhei Yamashita

Kawahara, 6068507, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 105 publications

Correction to: Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapy.

Correction to: Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapy.

Journal: International journal of hematology
Published: June 25, 2026

T-cell large granular lymphocyte leukaemia with pure red cell aplasia harbouring a somatic STAT3 P715L mutation.

T-cell large granular lymphocyte leukaemia with pure red cell aplasia harbouring a somatic STAT3 P715L mutation.

Journal: BMJ case reports
Published: June 05, 2026

Usefulness of pegfilgrastim for allogeneic peripheral blood stem cell collection from healthy donors.

Usefulness of pegfilgrastim for allogeneic peripheral blood stem cell collection from healthy donors.

Journal: Transfusion
Published: March 24, 2026

Impact of Acute Graft-Versus-Host Disease and Delayed Hematopoietic Recovery on the Incidence and Clinical Burden of Late Cytomegalovirus Reactivation and Disease after Letermovir Prophylaxis during the First 100 Days after Cord Blood Transplantation.

Impact of Acute Graft-Versus-Host Disease and Delayed Hematopoietic Recovery on the Incidence and Clinical Burden of Late Cytomegalovirus Reactivation and Disease after Letermovir Prophylaxis during the First 100 Days after Cord Blood Transplantation.

Journal: Transplantation and cellular therapy
Published: March 10, 2026

Prolonged Cytokine Release Syndrome is Associated with Hypofibrinogenemia after CD19-Directed CAR T-Cell Therapy in Adult Patients with Relapsed/Refractory Lymphoma.

Prolonged Cytokine Release Syndrome is Associated with Hypofibrinogenemia after CD19-Directed CAR T-Cell Therapy in Adult Patients with Relapsed/Refractory Lymphoma.

Journal: Transplantation and cellular therapy
Published: March 04, 2026

A diagnostic pitfall in cold agglutinin disease: KMT2D-mutated CAD-associated lymphoproliferative disorder with a CLL-like immunophenotype.

A diagnostic pitfall in cold agglutinin disease: KMT2D-mutated CAD-associated lymphoproliferative disorder with a CLL-like immunophenotype.

Journal: Oxford medical case reports
Published: January 04, 2026

Hemostatic rescue with rFVIIa in Bernard-Soulier syndrome refractory to HLA-matched platelet transfusion.

Hemostatic rescue with rFVIIa in Bernard-Soulier syndrome refractory to HLA-matched platelet transfusion.

Journal: Annals of hematology
Published: November 10, 2025

Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapy.

Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapy.

Journal: International journal of hematology
Published: October 04, 2025

Effect of Early Administration of Anti-MRSA Drugs for Febrile Neutropenia in Allogeneic Hematopoietic Cell Transplantation.

Effect of Early Administration of Anti-MRSA Drugs for Febrile Neutropenia in Allogeneic Hematopoietic Cell Transplantation.

Journal: EJHaem
Published: September 28, 2025

Low reticulocyte count at infusion is a risk factor for ICANS in CAR-T cell therapy.

Low reticulocyte count at infusion is a risk factor for ICANS in CAR-T cell therapy.

Journal: Cytotherapy
Published: September 07, 2025

Association of serum myokine levels with rapid degeneration in skeletal muscle quality following allogeneic hematopoietic stem cell transplantation.

Association of serum myokine levels with rapid degeneration in skeletal muscle quality following allogeneic hematopoietic stem cell transplantation.

Journal: Nutrition (Burbank, Los Angeles County, Calif.)
Published: July 07, 2025

Impact of venetoclax trough levels on safety and efficacy in the treatment of acute myeloid leukemia.

Impact of venetoclax trough levels on safety and efficacy in the treatment of acute myeloid leukemia.

Journal: Scientific reports
Published: June 28, 2025
Showing 1-12 of 105

Last Updated: 09/26/2026